2021 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar

2021年肺发育、损伤与修复戈登研究会议暨戈登研究研讨会

• 批准号: 10217714
• 负责人: Daniel J. Tschumperlin
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-06-10 至 2022-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10217714
• 关键词: Address; Area; Asthma; Automobile Driving; Biological; Biology; Biomedical Engineering; COVID-19 pandemic; Career Mobility; Cells; Cellular biology; Cessation of life; Chronic; Chronic Obstructive Airway Disease; Chronic lung disease; Clinical; Collaborations; Data; Development; Diagnosis; Disabled Persons; Disease; Early Diagnosis; Ensure; Faculty; Fostering; Funding; Gender; Geography; Growth; Health; Injury; Investments; Long COVID; Lung; Lung diseases; Medicine; Mentors; Molecular; Molecular Biology; Physicians; Physiology; Population; Positioning Attribute; Postdoctoral Fellow; Pulmonary Fibrosis; Race; Research; Research Personnel; Role; SARS-CoV-2 infection; Scientist; Senior Scientist; Structure; Therapeutic; Time; Tissues; Translating; Translations; Underrepresented Minority; Viral; Woman; World Health Organization; career; cohort; experience; graduate student; human disease; injury and repair; knowledge integration; lung development; lung injury; meetings; next generation; novel; peer; peer networks; premature; pulmonary function; repaired; respiratory; restoration; severe injury; symposium; translational scientist

Project Summary: The 2021 Lung Development, Injury and Repair Gordon Research Conference (GRC) and associated Gordon Research Seminar (GRS) will be held August 14-20, 2021 in Waterville Valley, NH. The theme for the 2021 Lung GRC is "Biological Discoveries to Transform Respiratory Medicine". This meeting comes at a critical time, as the prolonged consequences of severe lung injuries associated with the COVID-19 pandemic will be coming into focus, heightening our need to understand, and ultimately counteract, the dysfunctional repair and remodeling that follows severe injury. Moreover, the growing global burden of lung disease continues unabated, with some 4 million premature deaths annually worldwide attributed to chronic respiratory diseases, including COPD, asthma, and pulmonary fibrosis, according to the World Health Organization. While investments in basic scientific research continue to accelerate substantial strides forward in understanding molecular, cellular and tissue level mechanisms driving respiratory diseases, translation of these findings toward early detection and effective repair and restoration of lung function in chronic respiratory diseases remains a major barrier. Meeting this challenge requires the integration of knowledge from experts spanning lung development, molecular and cell biology, physiology, bioengineering, matrix biology as well as physicians and translational experts immersed in the diagnosis and treatment of human disease. This conference will bring this diversity of expertise together to disseminate and debate the latest findings in the fields of lung development, injury and repair, and to formulate the new ideas, collaborations and approaches that will be needed to translate biologic discoveries toward meaningful advances in respiratory medicine. A major emphasis of the Lung GRC and GRS is to strengthen the pipeline of scientists and clinicians focused on lung development, injury and repair. Funds from this R13 will be specifically targeted to promote participation in the conference by women, under-represented minorities and people with disabilities, particularly graduate students, postdoctoral fellows, and early career investigators. The unique attributes of the GRC (small, secluded, unpublished data, abundant time for discussion) and GRS (close trainee interactions with peers and seniors) formats provide an opportunity for formal and informal interactions and collaborations that are likely to have significant and sustained impact on the field. The Lung Development, Injury and Repair GRC/GRS will thus promote accelerated progress in understanding and treating chronic lung diseases, and help to ensure the vitality and growth of a diverse pipeline of clinicians and scientists capable of addressing the growing burden of lung diseases.

项目摘要： 2021年肺发展，伤害和维修戈登研究会议（GRC）和相关的戈登 研究研讨会（GRS）将于2021年8月14日至201日在新罕布什尔州沃特维尔山谷举行。 2021的主题 肺GRC是“改变呼吸医学的生物学发现”。这次会议是在关键的时间 随着与199大流行有关的严重肺部损伤的长期后果即将到来 集中精力，提高我们理解并最终抵消功能失调的维修以及 重塑后重伤。此外，肺部疾病的全球负担不断增长 尚未减弱，每年大约有400万个过早死亡归因于慢性呼吸道疾病， 据世界卫生组织称，包括COPD，哮喘和肺纤维化。尽管 对基础科学研究的投资继续加快理解方面的大步进步 分子，细胞和组织水平机制驱动呼吸道疾病，这些发现的翻译 早期检测以及慢性呼吸道疾病中肺功能的有效修复和恢复 仍然是一个主要障碍。应对这一挑战需要跨越专家的知识的整合 肺发育，分子和细胞生物学，生理学，生物工程，基质生物学以及医生 转化专家沉浸在人类疾病的诊断和治疗中。这次会议将 将这些专业知识的多样性融合在一起，以传播和辩论肺部领域的最新发现 开发，伤害和维修，并制定将来的新想法，合作和方法 需要将生物学发现转化为有意义的呼吸医学进步。专业 肺GRC和GRS的重点是加强科学家和临床医生的管道。 开发，伤害和维修。该R13的资金将是专门针对的，以促进参与 妇女会议，代表性不足的少数民族和残疾人，特别是毕业生 学生，博士后研究员和早期职业调查员。 GRC的独特属性（小， 僻静的，未发表的数据，大量讨论时间）和GRS（密切的学员与同行的互动， 老年人）格式为正式和非正式互动和合作提供了机会 对该领域产生重大和持续的影响。肺发育，受伤和修复GRC/GRS将 因此，在理解和治疗慢性肺部疾病方面促进了加速进步，并有助于确保 临床医生和科学家的多样化管道的活力和生长能够解决日益增长的负担 肺部疾病。